Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome Life Science Investing
Rain Enhancement Technologies Secures Second U.S. Installation with Utah Permit Approval, Advances Snow Enhancement Capabilities Life Science Investing
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting Life Science Investing
Nextech3D.ai Accelerates Eventdex Integration; Expands AI Matchmaking and Achieves Milestone Production of 800 Interactive Floor Plans in 2025 Artificial Intelligence Investing
Anavex Life Sciences to Announce Fiscal 2025 Fourth Quarter Financial Results on Tuesday, November 25, 2025 Life Science Investing
Rakovina Therapeutics' President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit Life Science Investing
